Uncategorized

Femtech Trendwatch: Investment Round-up, Hims&Hers goes Hybrid & Provider-focused Healthcare Innovation

Every Monday we share a quick “best of” from the week that was with our Inner Circle members. What’s trending in the Femtech Insider community and beyond? We’ve got you covered! In this week’s brief we talk about last month’s women’s health investments plus… Hims/Hers goes Hybrid A Provider-focused Approach to Healthcare Disruption Startup Spotlight 🌟 And more! Femtech Investment Round-up: March 2022 As every month we share an overview…

What’s New in Femtech This Week? (March 3, 2022)

Every Thursday we send out a curated newsletter on “all things femtech and women’s health innovation”. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page. Image: Thinx Highlights Kimberly-Clarkacquires a majority stake in Thinx. You’ve found some of our exclusive Inner Circle Content. This article is only available for our Inner Circle Members.…

What’s New in Femtech This Week? (Jan 13, 2022)

Every Thursday we send out a curated newsletter on “all things femtech and women’s health innovation”. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page. “Ovaries age five times faster than other organs, resulting in infertility, early menopause and increased years of poor health for women. We want to change the…

Organon Completes the Acquisition of Forendo Pharma, a Biotech Firm Focused on Women’s Health

Women’s Health Pharma company and Merck spin-off Organon, has completed its recently announced acquisition of Forendo Pharma, a clinical-stage drug development company focused on novel treatments in women’s health. Forendo’s lead candidate, FOR-6219, is an investigational, potentially first-in-class oral 17β-hydroxysteroid dehydrogenase type 1 (HSD17B1) inhibitor entering Phase 2 clinical development for endometriosis. Forendo’s pipeline also includes a preclinical program targeting polycystic ovarian…

What’s New in Femtech This Week? (Dec 16, 2021)

Every Thursday we send out a curated newsletter on “all things femtech and women’s health innovation”. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page. “Saving one’s hair is not about vanity. It’s about recognizing yourself in the mirror; it’s about privacy, dignity, and not letting cancer take your identity from…

Hims & Hers Adds 10 New Members to its Medical Advisory Board

Hims & Hers, the multi-specialty telehealth platform, is expanding the size and scope of its Medical Advisory Board as it continues expanding more recent medical verticals such as mental health and primary care, and further growing early focus areas, such as sexual health, dermatology, and hair loss. The Medical Advisory board, which advises the company as it works to create access to…

Femtech Trendwatch: A Win for Femtech Advertising, Center of Intimacy Justice & Major Trends in Medicaid

Every Monday we share a quick “best of” from the week that was with our Inner Circle members. Curious what’s trending in the Femtech Insider community and beyond? We’ve got you covered! In this week’s brief we talk about Dame’s Settlement with the MRT, plus… Major Trends in Medicaid Event: Trends at the Intersection of Beauty and Women’s Health A Win for Femtech…

What’s New in Femtech This Week? (Nov 18, 2021)

Every Thursday we send out a curated newsletter on “all things femtech and women’s health innovation”. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page. “Sexual pleasure is a critical part of wellbeing. Denying Dame advertising space stifles our ability to articulate the value we bring; to innovate and develop products…